Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Here are some trading bets from Mehraboon Irani

      In an interview to Latha Venkatesh and Anuj Singhal on CNBC-TV18, Mehraboon Irani of Nirmal Bang Securities spoke about the current market trends and specific stocks and sectors.

    • Look at Sun Pharma, says Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas is of the view that one may look at Sun Pharmaceutical Industries.

    • Sun Pharma looks good for long term: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that Sun Pharma is looking good for long term.

    • Here are a few stock ideas from Mayuresh Joshi

      In an interview to CNBC-TV18, Mayuresh Joshi, Fund Manager (PMS) at Angel Broking Ltd shared his readings and outlook on specific stocks and sectors.

    • Here are a few stock ideas from Prakash Diwan

      In an interview to CNBC-TV18, Prakash Diwan of prakashdiwan.in shared his readings and outlook on specific stocks and sector.

    • Six in Sixty: Stocks you should keep on your radar

      CNBC-TV18's Ekta Batra lists six stocks that you should focus on - Infosys, Sun Pharmaceuticals, Lupin, Aurobindo Pharma, Bank Nifty, BHEL, HPCL, and Welspun India.

    • Prefer HDFC, says Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one may prefer HDFC.

    • Investment strategies: 3 Bumper stocks to strike gold

      Credit Suisse maintains outperform on Strides Shasun expecting recovery in H2FY17. It has cut estimates by 30 percent/22 percent in 2017/18 to factor in API weakness. It says margin may hit 20 percent in second half with recovery in Africa business.

    • Buy Reliance Capital, Hindalco; sell Sun Pharma: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one can buy Reliance Capital and Hindalco Industries and sell Sun Pharma.

    • Investment strategies: Top 5 stocks that you can focus today

      CLSA says large deal loss puts FY17 guidance of Infosys at risk after weak Q1. It may impact FY17 revenue by USD 50-100 million and FY18 revenue by USD 100-200 million. Its sya RBS deal cancellation puts FY17 revenue guidance at risk by 0.5-1 percent.

    • Investment strategies: 7 money spinner stocks that you can buy

      Deutsche Bank reiterates buy rating on Sun Pharma, with a target price of Rs 900 per share. It says delay in resolving the warning letter at the Halol plant a downside risk.

    • Like Sun Pharma, can climb to Rs 860; HPCL looks weak: Gaba

      Prakash Gaba of prakashgaba.com likes Sun Pharma and feels that the stock can climb to Rs 860.

    • See upside in Sun Pharma, rally in Coal India: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may see upside in Sun Pharma and a rally in Coal India.

    • Here are a few stocks ideas from Prakash Diwan

      In an interview to CNBC-TV18, Prakash Diwan of prakashdiwan.in shared his readings and outlook on specific stocks and sectors.

    • Book some profits in Sun Pharma: Avinash Gorakshakar

      Avinash Gorakshakar, Market Expert is of the view that one may book some profits in Sun Pharmaceutical Industries.

    • Buy Reliance Capital 450 Call, Sun Pharma 840 Call: VK Sharma

      VK Sharma of HDFC Securities is of the view that one can buy Reliance Capital 450 Call and Sun Pharma 840 Call.

    • Sun Pharma best among pharma stocks, Biocon may hit Rs 845: Bose

      Rajat Bose of rajatkbose.com is of the view that Sun Pharma is the best stocks in pharma space and feels that Biocon may hit Rs 845.

    • Buy Sun Pharma; Ajanta Pharma better than Lupin: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Sun Pharma and feels that Ajanta Pharma better than Lupin.

    • Buy Voltas, target Rs 355: Rahul Mohindar

      According to Rahul Mohindar of viratechindia.com, one can buy Voltas for target of Rs 355.

    • Buy Hindustan Unilever, Cipla: Rahul Mohindar

      Rahul Mohindar of viratechindia.com recommends buying Hindustan Unilever for target of Rs 940-50 and Cipla for target of Rs 560.

    • Buy SBI, Hero Moto, Bajaj Auto, Maruti, Lupin: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying SBI, Hero Moto, Bajaj Auto, Maruti Suzuki and Lupin.

    • Prefer Sun Pharma, Dr Reddy's Lab: Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com is of the view that one may prefer Sun Pharmaceutical Industries and Dr Reddy's Laboratories.

    • Hold Lupin, Sun Pharma: Ambareesh Baliga

      Ambareesh Baliga, Market Expert is of the view that one can hold Lupin and Sun Pharma.

    • Buy DHFL, M&M Fin, Reliance Infra, SPARC: Ashwani Gujral

      According to Ashwani Gujral of ashwanigujral.com, one can buy DHFL, Mahindra and Mahindra Financial Services, Reliance Infrastructure and Sun Pharma Advanced Research Company.

    • Buy Rural Electrification Corporation, Sun Pharma: Rahul Shah

      Acording to Rahul Shah of Motilal Oswal, one can buy Rural Electrification Corporation and Sun Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347